Traumatic Brain Injury in Patients under Anticoagulant Therapy: Review of Management in Emergency Department
Abstract
:1. Background
1.1. Definition and Epidemiology
1.2. The Special Case of mTBI
2. Literature Search Strategy
3. Diagnosis and Risk Stratification
3.1. Guidelines
3.2. Clinical Decision Rules
3.3. Role of Biomarkers
4. Management: Not Only Neurosurgery
4.1. Setting: Intensive Care Unit/Neurosurgery/Emergency Department
4.2. Observation and CT Repeating
4.3. Assessment of the Extent of Anticoagulation
4.4. Reversing Anticoagulation
4.4.1. Idarucizumab: Antidote for Direct Thrombin Inhibitor
4.4.2. Andexanet Alfa: Universal Antidote for Factor Xa Inhibitors
4.5. Tranexamic Acid
4.6. Indications for Neurosurgery
4.7. Prophylaxis and Anticoagulant Resumption after TBI
5. Complications
5.1. Delayed Intracranial Injuries
5.2. TBI-Induced Coagulopathy
6. The Economic Burden
7. Future Directions: The Role of Artificial Intelligence-Assisted Decision
8. Conclusions: A New Classic Topic with New Answers
Supplementary Materials
Funding
Conflicts of Interest
References
- Faul, M.; Xu, L.; Wald, M.M.; Coronado, V.G. Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths 2002–2006; Centers for Disease Control and Prevention, National Center for Injury Prevention and Control: Atlanta, GA, USA, 2010. [Google Scholar]
- Pandor, A.; Harnan, S.; Goodacre, S.; Pickering, A.; Fitzgerald, P.; Rees, A. Diagnostic accuracy of clinical characteristics for identifying CT abnormality after minor brain injury: A systematic review and meta-analysis. J. Neurotrauma 2012, 29, 707–718. [Google Scholar] [CrossRef] [PubMed]
- Maas, A.I.R.; Menon, D.K.; Adelson, P.D.; Andelic, N.; Bell, M.J.; Belli, A.; Bragge, P.; Brazinova, A.; Büki, A.; Chesnut, R.M.; et al. Traumatic brain injury: Integrated approaches to improve prevention, clinical care, and research. Lancet Neurol. 2017, 16, 987–1048. [Google Scholar] [CrossRef] [PubMed]
- Barnes, G.D.; Lucas, E.; Alexander, G.C.; Goldberger, Z.D. National Trends in Ambulatory Oral Anticoagulant Use. Am. J. Med. 2015, 128, 1300–1305.e2. [Google Scholar] [CrossRef] [PubMed]
- Vedin, T.; Lundager Forberg, J.; Anefjäll, E.; Lehtinen, R.; Faisal, M.; Edelhamre, M. Antiplatelet therapy contributes to a higher risk of traumatic intracranial hemorrhage compared to anticoagulation therapy in ground-level falls: A single-center retrospective study. Eur. J. Trauma Emerg. Surg. 2022, 48, 4909–4917. [Google Scholar] [CrossRef] [PubMed]
- Levin, H.S.; Diaz-Arrastia, R.R. Diagnosis, prognosis, and clinical management of mild traumatic brain injury. Lancet Neurol. 2015, 14, 506–517. [Google Scholar] [CrossRef] [PubMed]
- Carroll, L.J.; Cassidy, J.D.; Holm, L.; Kraus, J.; Coronado, V.G.; WHO Collaborating Centre Task Force on Mild Traumatic Brain Injury. Methodological issues and research recommendations for mild traumatic brain injury: The WHO Collaborating Centre Task Force on Mild Traumatic Brain Injury. J. Rehabil. Med. 2004, 43, 113–125. [Google Scholar] [CrossRef] [PubMed]
- Kay, T.; Harrington, D.E.; Adams, R.; Anderson, T.; Berrol, S.; Cicerone, K.; Dahlberg, C.; Gerber, D.; Goka, R.; Haley, P.; et al. ACRM Definition of mild traumatic brain injury. J. Head Trauma Rehabil. 1993, 8, 86–87. [Google Scholar] [CrossRef]
- Stein, S.C. Minor head injury: 13 is an unlucky number. J. Trauma 2001, 50, 759–760. [Google Scholar] [CrossRef]
- US Department of Veterans Affairs; US Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Concussion-Mild Traumatic Brain Injury. Available online: https://www.healthquality.va.gov/guidelines/Rehab/mtbi/mTBICPGFullCPG50821816.pdf (accessed on 10 April 2024).
- Menditto, V.G.; Lucci, M.; Polonara, S.; Pomponio, G.; Gabrielli, A. Management of minor head injury in patients receiving oral anticoagulant therapy: A prospective study of a 24-hour observation protocol. Ann. Emerg. Med. 2012, 59, 451–455. [Google Scholar] [CrossRef]
- Chenoweth, J.A.; Johnson, M.A.; Shook, L.; Sutter, M.E.; Nishijima, D.K.; Holmes, J.F. Prevalence of intracranial hemorrhage after blunt head trauma in patients on pre-injury dabigatran. West. J. Emerg. Med. 2017, 18, 794–799. [Google Scholar] [CrossRef]
- Nishijima, D.K.; Gaona, S.D.; Waechter, T.; Maloney, R.; Blitz, A.; Elms, A.R.; Farrales, R.D.; Montoya, J.; Bair, T.; Howard, C.; et al. The Incidence of Traumatic Intracranial Hemorrhage in Head-Injured Older Adults Transported by EMS with and without Anticoagulant or Antiplatelet Use. J. Neurotrauma 2018, 35, 750–759. [Google Scholar] [CrossRef] [PubMed]
- Maas, A.I.; Harrison-Felix, C.L.; Menon, D.; Adelson, P.D.; Balkin, T.; Bullock, R.; Engel, D.C.; Gordon, W.; Langlois-Orman, J.; Lew, H.L.; et al. Standardizing data collection in traumatic brain injury. J. Neurotrauma 2011, 28, 177–187. [Google Scholar] [CrossRef] [PubMed]
- American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Mild Traumatic Brain Injury; Valente, J.H.; Anderson, J.D.; Paolo, W.F.; Sarmiento, K.; Tomaszewski, C.A.; Haukoos, J.S.; Diercks, D.B.; Diercks, D.B.; Anderson, J.D.; et al. Clinical Policy: Critical Issues in the Management of Adult Patients Presenting to the Emergency Department With Mild Traumatic Brain Injury: Approved by ACEP Board of Directors, 1 February 2023 Clinical Policy Endorsed by the Emergency Nurses Association (5 April 2023). Ann. Emerg. Med. 2023, 81, e63–e105. [Google Scholar]
- McCrory, P.; Meeuwisse, W.; Dvořák, J.; Aubry, M.; Bailes, J.; Broglio, S.; Cantu, R.C.; Cassidy, D.; Echemendia, R.J.; Castellani, R.J.; et al. Consensus statement on concussion in sport-the 5th international conference on concussion in sport held in Berlin, October 2016. Br. J. Sports Med. 2017, 51, 838–847. [Google Scholar] [CrossRef] [PubMed]
- Mott, T.F.; McConnon, M.L.; Rieger, B.P. Subacute to chronic mild traumatic brain injury. Am. Fam. Physician 2012, 86, 1045–1051. [Google Scholar] [PubMed]
- Lefevre-Dognin, C.; Cogné, M.; Perdrieau, V.; Granger, A.; Heslot, C.; Azouvi, P. Definition and epidemiology of mild traumatic brain injury. Neurochirurgie 2021, 67, 218–221. [Google Scholar] [CrossRef] [PubMed]
- Vos, P.E.; Alekseenko, Y.; Battistin, L.; Ehler, E.; Gerstenbrand, F.; Muresanu, D.F.; Potapov, A.; Stepan, C.A.; Traubner, P.; Vecsei, L.; et al. Mild traumatic brain injury. Eur. J. Neurol. 2012, 19, 191–198. [Google Scholar] [CrossRef] [PubMed]
- Undén, J.; Ingebrigtsen, T.; Romner, B.; Scandinavian Neurotrauma Committee (SNC). Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: An evidence and consensus-based update. BMC Med. 2013, 11, 50. [Google Scholar] [CrossRef] [PubMed]
- Rajesh, S.; Wonderling, D.; Bernstein, I.; Balson, C.; Lecky, F.; Guideline Committee. Head injury: Assessment and early management-summary of updated NICE guidance. BMJ 2023, 381, 1130. [Google Scholar] [CrossRef] [PubMed]
- Joseph, B.; Friese, R.S.; Sadoun, M.; Aziz, H.; Kulvatunyou, N.; Pandit, V.; Wynne, J.; Tang, A.; O’Keeffe, T.; Rhee, P. The BIG (brain injury guidelines) project: Defining the management of traumatic brain injury by acute care surgeons. J. Trauma Acute Care Surg. 2014, 76, 965–996. [Google Scholar] [CrossRef]
- Wiegele, M.; Schöchl, H.; Haushofer, A.; Ortler, M.; Leitgeb, J.; Kwasny, O.; Beer, R.; Ay, C.; Schaden, E. Diagnostic and therapeutic approach in adult patients with traumatic brain injury receiving oral anticoagulant therapy: An Austrian interdisciplinary consensus statement. Crit. Care 2019, 23, 62. [Google Scholar] [CrossRef]
- Gallagher, S.P.; Capacio, B.A.; Rooney, A.S.; Schaffer, K.B.; Calvo, R.Y.; Sise, C.B.; Krzyzaniak, A.; Sise, M.J.; Bansal, V.; Biffl, W.L.; et al. Modified BRAIN INJURY GUIDELINE for pre-injury anticoagulation in traumatic brain injury: An opportunity to reduce healthcare resource utilization. J. Trauma Acute Care Surg. 2024, 96, 240–246. [Google Scholar] [CrossRef] [PubMed]
- Easter, J.S.; Haukoos, J.S.; Meehan, W.P.; Novack, V.; Edlow, J.A. Will Neuroimaging Reveal a Severe Intracranial Injury in This Adult with Minor Head Trauma? The Rational Clinical Examination Systematic Review. JAMA 2015, 314, 2672–2681. [Google Scholar] [CrossRef] [PubMed]
- Teeratakulpisarn, P.; Angkasith, P.; Wannakul, T.; Tanmit, P.; Prasertcharoensuk, S.; Thanapaisal, C.; Wongkonkitsin, N.; Kitkhuandee, A.; Sukeepaisarnjaroen, W.; Phuttharak, W.; et al. What are the strongest indicators of intracerebral hemorrhage in mild traumatic brain injury? Trauma Surg. Acute Care Open 2021, 6, e000717. [Google Scholar] [CrossRef] [PubMed]
- Mower, W.R.; Hoffman, J.R.; Herbert, M.; Wolfson, A.B.; Pollack, C.V., Jr.; Zucker, M.I.; NEXUS II Investigators. Developing a decision instrument to guide computed tomographic imaging of blunt head injury patients. J. Trauma 2005, 59, 954–959. [Google Scholar]
- Mower, W.R.; Gupta, M.; Rodriguez, R.; Hendey, G.W. Validation of the sensitivity of the National Emergency X-Radiography Utilization Study (NEXUS) Head computed tomographic (CT) decision instrument for selective imaging of blunt head injury patients: An observational study. PLoS Med. 2017, 14, e1002313. [Google Scholar] [CrossRef] [PubMed]
- Stiell, I.G.; Wells, G.A.; Vandemheen, K.; Clement, C.; Lesiuk, H.; Laupacis, A.; McKnight, R.D.; Verbeek, R.; Brison, R.; Cass, D.; et al. The Canadian CT Head Rule for patients with minor head injury. Lancet 2001, 357, 1391–1396. [Google Scholar] [CrossRef] [PubMed]
- Haydel, M.J.; Preston, C.A.; Mills, T.J.; Luber, S.; Blaudeau, E.; DeBlieux, P.M. Indications for computed tomography in patients with minor head injury. N. Engl. J. Med. 2000, 343, 100–105. [Google Scholar] [CrossRef] [PubMed]
- Alzuhairy, A.K.A. Accuracy of Canadian CT Head Rule and New Orleans Criteria for Minor Head Trauma; a Systematic Review and Meta-Analysis. Arch. Acad. Emerg. Med. 2020, 8, e79. [Google Scholar] [PubMed]
- Smits, M.; Dippel, D.W.; Steyerberg, E.W.; de Haan, G.G.; Dekker, H.M.; Vos, P.E.; Kool, D.R.; Nederkoorn, P.J.; Hofman, P.A.; Twijnstra, A.; et al. Predicting intracranial traumatic findings on computed tomography in patients with minor head injury: The CHIP prediction rule. Ann. Intern. Med. 2007, 146, 397–405. [Google Scholar] [CrossRef]
- Cipriano, A.; Park, N.; Pecori, A.; Bionda, A.; Bardini, M.; Frassi, F.; Lami, V.; Leoli, F.; Manca, M.L.; Del Prato, S.; et al. Predictors of post-traumatic complication of mild brain injury in anticoagulated patients: DOACs are safer than VKAs. Intern. Emerg. Med. 2021, 16, 1061–1070. [Google Scholar] [CrossRef]
- Uccella, L.; Zoia, C.; Bongetta, D.; Gaetani, P.; Martig, F.; Candrian, C.; Rosso, R. Are Antiplatelet and Anticoagulants Drugs A Risk Factor for Bleeding in Mild Traumatic Brain Injury? World Neurosurg. 2018, 110, e339–e345. [Google Scholar] [PubMed]
- Fuller, G.W.; Evans, R.; Preston, L.; Woods, H.B.; Mason, S. Should Adults with Mild Head Injury Who Are Receiving Direct Oral Anticoagulants Undergo Computed Tomography Scanning? A Systematic Review. Ann. Emerg. Med. 2019, 73, 66–75. [Google Scholar] [CrossRef]
- Turcato, G.; Zannoni, M.; Zaboli, A.; Zorzi, E.; Ricci, G.; Pfeifer, N.; Maccagnani, A.; Tenci, A.; Bonora, A. Direct Oral Anticoagulant Treatment and Mild Traumatic Brain Injury: Risk of Early and Delayed Bleeding and the Severity of Injuries Compared with Vitamin K Antagonists. J. Emerg. Med. 2019, 57, 817–824. [Google Scholar] [CrossRef]
- Turcato, G.; Zaboli, A.; Zannoni, M.; Ricci, G.; Zorzi, E.; Ciccariello, L.; Tenci, A.; Pfeifer, N.; Maccagnani, A.; Bonora, A. Risk factors associated with intracranial bleeding and neurosurgery in patients with mild traumatic brain injury who are receiving direct oral anticoagulants. Am. J. Emerg. Med. 2021, 43, 180–185. [Google Scholar] [CrossRef] [PubMed]
- Turcato, G.; Zaboli, A.; Pfeifer, N.; Maccagnani, A.; Tenci, A.; Giudiceandrea, A.; Zannoni, M.; Ricci, G.; Bonora, A.; Brigo, F. Decision tree analysis to predict the risk of intracranial haemorrhage after mild traumatic brain injury in patients taking DOACs. Am. J. Emerg. Med. 2021, 50, 388–393. [Google Scholar] [CrossRef] [PubMed]
- Fuller, G.; Sabir, L.; Evans, R.; Bradbury, D.; Kuczawski, M.; Mason, S.M. Risk of significant traumatic brain injury in adults with minor head injury taking direct oral anticoagulants: A cohort study and updated meta-analysis. Emerg. Med. J. 2020, 37, 666–673. [Google Scholar] [CrossRef] [PubMed]
- Park, N.; Barbieri, G.; Turcato, G.; Cipriano, A.; Zaboli, A.; Giampaoli, S.; Bonora, A.; Ricci, G.; Santini, M.; Ghiadoni, L. Multi-centric study for development and validation of a CT head rule for mild traumatic brain injury in direct oral anticoagulants: The HERO-M nomogram. BMC Emerg. Med. 2023, 23, 122. [Google Scholar] [CrossRef] [PubMed]
- Turcato, G.; Cipriano, A.; Park, N.; Zaboli, A.; Ricci, G.; Riccardi, A.; Barbieri, G.; Gianpaoli, S.; Guiddo, G.; Santini, M.; et al. Decision tree analysis for assessing the risk of post-traumatic haemorrhage after mild traumatic brain injury in patients on oral anticoagulant therapy. BMC Emerg. Med. 2022, 22, 47. [Google Scholar] [CrossRef]
- Menditto, V.G.; Moretti, M.; Babini, L.; Sampaolesi, M.; Buzzo, M.; Montillo, L.; Raponi, A.; Riccomi, F.; Marcosignori, M.; Rocchi, M.; et al. Minor head injury in anticoagulated patients: Outcomes and analysis of clinical predictors. A prospective study. Am. J. Emerg. Med. 2023, 76, 105–110. [Google Scholar] [CrossRef]
- Zetterberg, H.; Blennow, K. Fluid biomarkers for mild traumatic brain injury and related conditions. Nat. Rev. Neurol. 2016, 12, 563–574. [Google Scholar] [CrossRef]
- Wang, K.K.; Yang, Z.; Zhu, T.; Shi, Y.; Rubenstein, R.; Tyndall, J.A.; Manley, G.T. An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert Rev. Mol. Diagn. 2018, 18, 165–180. [Google Scholar] [CrossRef] [PubMed]
- Bazarian, J.J.; Biberthaler, P.; Welch, R.D.; Lewis, L.M.; Barzo, P.; Bogner-Flatz, V.; Gunnar Brolinson, P.; Büki, A.; Chen, J.Y.; Christenson, R.H.; et al. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): A multicentre observational study. Lancet Neurol. 2018, 17, 782–789. [Google Scholar] [CrossRef] [PubMed]
- Rogan, A.; O’Sullivan, M.B.; Holley, A.; McQuade, D.; Larsen, P. Can serum biomarkers be used to rule out significant intracranial pathology in emergency department patients with mild traumatic brain injury? A Systemic Review & Meta-Analysis. Injury 2022, 53, 259–271. [Google Scholar] [PubMed]
- Biberthaler, P.; Linsenmeier, U.; Pfeifer, K.J.; Kroetz, M.; Mussack, T.; Kanz, K.G.; Hoecherl, E.F.; Jonas, F.; Marzi, I.; Leucht, P.; et al. Serum S-100B concentration provides additional information fot the indication of computed tomography in patients after minor head injury: A prospective multicenter study. Shock 2006, 25, 446–453. [Google Scholar] [CrossRef]
- Laribi, S.; Kansao, J.; Borderie, D.; Collet, C.; Deschamps, P.; Ababsa, R.; Mouniam, L.; Got, L.; Leon, A.; Thoannes, H.; et al. S100B blood level measurement to exclude cerebral lesions after minor head injury: The multicenter STIC-S100 French study. Clin. Chem. Lab. Med. 2014, 52, 527–536. [Google Scholar] [CrossRef]
- Morochovic, R.; Rácz, O.; Kitka, M.; Pingorová, S.; Cibur, P.; Tomková, D.; Lenártová, R. Serum S100B protein in early management of patients after mild traumatic brain injury. Eur. J. Neurol. 2009, 16, 1112–1117. [Google Scholar] [CrossRef] [PubMed]
- Blais Lécuyer, J.; Mercier, É.; Tardif, P.A.; Archambault, P.M.; Chauny, J.M.; Berthelot, S.; Frenette, J.; Perry, J.; Stiell, I.; Émond, M.; et al. S100B protein level for the detection of clinically significant intracranial haemorrhage in patients with mild traumatic brain injury: A subanalysis of a prospective cohort study. Emerg. Med. J. 2021, 38, 285–289. [Google Scholar] [CrossRef] [PubMed]
- Seidenfaden, S.C.; Kjerulff, J.L.; Juul, N.; Kirkegaard, H.; Møller, M.F.; Münster, A.B.; Bøtker, M.T. Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: A prospective observational multicenter cohort study—“the PreTBI I study”. Scand. J. Trauma Resusc. Emerg. Med. 2021, 29, 75. [Google Scholar] [CrossRef]
- Prise en Charge des Patients Presentant un Traumatisme Crânien leger de L’adulte [Management of Patients Suffering from Mild Traumatic Brain Injury] RPP-TCL-2022.pdf—SFMU. Available online: https://www.sfmu.org/upload/consensus/RPP-TCL-2022.pdf (accessed on 9 April 2024).
- Temboury Ruiz, F.; Moya Torrecilla, M.; Arráez Sánchez, M.A.; Arribas Gómez, I.; Vicente Bártulos, A.; Gallego España, F.J.; Menacho Román, M.; Morales Rodríguez, A.; Morell-García, D.; Pecharromán de las Heras, I.; et al. Traumatismo craneoencefálico leve y biomarcadores de lesión cerebral aguda. Rev. Esp. Urg. Emerg. 2024, 3, 31–36. [Google Scholar]
- David, A.; Mari, C.; Vignaud, F.; Masson, D.; Planche, L.; Bord, E.; Bourcier, R.; Frampas, E.; Batard, E.; Desal, H. Evaluation of S100B blood level as a biomarker to avoid computed tomography in patients with mild head trauma under antithrombotic medication. Diagn. Interv. Imaging. 2017, 98, 551–556. [Google Scholar] [CrossRef]
- Menditto, V.G.; Moretti, M.; Babini, L.; Mattioli, A.; Giuliani, A.R.; Fratini, M.; Pallua, F.Y.; Andreoli, E.; Nitti, C.; Contucci, S.; et al. Minor head injury in anticoagulated patients: Performance of biomarkers S100B, NSE, GFAP, UCH-L1 and Alinity TBI in the detection of intracranial injury. A prospective observational study. Clin. Chem. Lab. Med. 2024, 62, 1376–1382. [Google Scholar] [CrossRef] [PubMed]
- Ward, M.D.; Weber, A.; Merrill, V.D.; Welch, R.D.; Bazarian, J.J.; Christenson, R.H. Predictive Performance of Traumatic Brain Injury Biomarkers in High-Risk Elderly Patients. J. Appl. Lab. Med. 2020, 5, 91–100. [Google Scholar] [CrossRef] [PubMed]
- Korhonen, O.; Mononen, M.; Mohammadian, M.; Tenovuo, O.; Blennow, K.; Hossain, I.; Hutchinson, P.; Maanpää, H.R.; Menon, D.K.; Newcombe, V.F.; et al. Outlier Analysis for Acute Blood Biomarkers of Moderate and Severe Traumatic Brain Injury. J. Neurotrauma 2024, 41, 91–105. [Google Scholar] [CrossRef] [PubMed]
- Richter, S.; Czeiter, E.; Amrein, K.; Mikolic, A.; Verheyden, J.; Wang, K.; Maas, A.I.R.; Steyerberg, E.; Büki, A.; Menon, D.K.; et al. Prognostic Value of Serum Biomarkers in Patients with Moderate-Severe Traumatic Brain Injury, Differentiated by Marshall Computer Tomography Classification. J. Neurotrauma 2023, 40, 2297–2310. [Google Scholar] [CrossRef] [PubMed]
- Åkerlund, C.A.I.; Holst, A.; Bhattacharyay, S.; Stocchetti, N.; Steyerberg, E.; Smielewski, P.; Menon, D.K.; Ercole, A.; Nelson, D.W.; CENTER-TBI participants and investigators. Clinical descriptors of disease trajectories in patients with traumatic brain injury in the intensive care unit (CENTER-TBI): A multicentre observational cohort study. Lancet Neurol. 2024, 23, 71–80. [Google Scholar] [CrossRef] [PubMed]
- Yuguero, O.; Bernal, M.; Farré, J.; Martinez-Alonso, M.; Vena, A.; Purroy, F. Clinical complications after a traumatic brain injury and its relation with brain biomarkers. Sci. Rep. 2023, 13, 20057. [Google Scholar] [CrossRef] [PubMed]
- Minhas, H.; Welsher, A.; Turcotte, M.; Eventov, M.; Mason, S.; Nishijima, D.K.; Versmée, G.; Li, M.; de Wit, K. Incidence of intracranial bleeding in anticoagulated patients with minor head injury: A systematic review and meta-analysis of prospective studies. Br. J. Haematol. 2018, 183, 119–126. [Google Scholar] [CrossRef] [PubMed]
- Santing, J.A.L.; Lee, Y.X.; van der Naalt, J.; van den Brand, C.L.; Jellema, K. Mild Traumatic Brain Injury in Elderly Patients Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis. J. Neurotrauma 2022, 39, 458–472. [Google Scholar] [CrossRef] [PubMed]
- Van Ornam J, Pruitt P, Borczuk P: Is repeat head CT necessary in patients with mild traumatic intracranial hemorrhage. Am. J. Emerg. Med. 2019, 37, 1694–1698. [CrossRef]
- Lobato, R.D.; Alen, J.F.; Perez-Nuñez, A.; Alday, R.; Gómez, P.A.; Pascual, B.; Lagares, A.; Miranda, P.; Arrese, I.; Kaen, A. Utilidad de la TAC secuencial y la monitorización de la presión intracraneal para detectar nuevo efecto masa intracraneal en pacientes con traumatismo craneal grave y lesión inicial Tipo I-II [Value of serial CT scanning and intracranial pressure monitoring for detecting new intracranial mass effect in severe head injury patients showing lesions type I-II in the initial CT scan]. Neurocirugia 2005, 16, 217–234. [Google Scholar]
- Brown, C.V.; Zada, G.; Salim, A.; Inaba, K.; Kasotakis, G.; Hadjizacharia, P.; Demetriades, D.; Rhee, P. Indications for routine repeat head computed tomography (CT) stratified by severity of traumatic brain injury. J. Trauma 2007, 62, 1339–1345. [Google Scholar] [CrossRef] [PubMed]
- Connon, F.F.; Namdarian, B.; Ee, J.L.; Drummond, K.J.; Miller, J.A. Do routinely repeated computed tomography scans in traumatic brain injury influence management? A prospective observational study in a level 1 trauma center. Ann. Surg. 2011, 254, 1028–1031. [Google Scholar] [CrossRef] [PubMed]
- Carney, N.; Totten, A.M.; O’Reilly, C.; Ullman, J.S.; Hawryluk, G.W.; Bell, M.J.; Bratton, S.L.; Chesnut, R.; Harris, O.A.; Kissoon, N.; et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Neurosurgery 2017, 80, 6–15. [Google Scholar] [CrossRef] [PubMed]
- Kuruvilla, M.; Gurk-Turner, C. A review of warfarin dosing and monitoring. Proc. (Bayl. Univ. Med. Cent.) 2001, 14, 305–306. [Google Scholar] [CrossRef] [PubMed]
- Gosselin, R.C.; Adcock, D.M.; Bates, S.M.; Douxfils, J.; Favaloro, E.J.; Gouin-Thibault, I.; Guillermo, C.; Kawai, Y.; Lindhoff-Last, E.; Kitchen, S. International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants. Thromb. Haemost. 2018, 118, 437–450. [Google Scholar] [CrossRef] [PubMed]
- Douxfils, J.; Ageno, W.; Samama, C.M.; Lessire, S.; Ten Cate, H.; Verhamme, P.; Dogné, J.M.; Mullier, F. Laboratory testing in patients treated with direct oral anticoagulants: A practical guide for clinicians. J. Thromb. Haemost. 2018, 16, 209–219. [Google Scholar] [CrossRef] [PubMed]
- Salmonson, T.; Dogne, J.M.; Janssen, H.; Garcia Burgos, J.; Blake, P. Non-vitamin-K oral anticoagulants and laboratory testing: Now and in the future: Views from a workshop at the European Medicines Agency (EMA). Eur. Heart J. Cardiovasc. Pharmacother. 2017, 3, 42–47. [Google Scholar] [CrossRef]
- van Ryn, J.; Baruch, L.; Clemens, A. Interpretation of point-of-care INR results in patients treated with dabigatran. Am. J. Med. 2012, 125, 417–420. [Google Scholar] [CrossRef]
- Patel, J.P.; Byrne, R.A.; Patel, R.K.; Arya, R. Progress in the monitoring of direct oral anticoagulant therapy. Br. J. Haematol. 2019, 184, 912–924. [Google Scholar] [CrossRef]
- Kustos, S.A.; Fasinu, P.S. Medicines Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update. Available online: www.mdpi.com/journal/medicines (accessed on 26 February 2024).
- Pollack, C.V., Jr.; Reilly, P.A.; van Ryn, J.; Eikelboom, J.W.; Glund, S.; Bernstein, R.A.; Dubiel, R.; Huisman, M.V.; Hylek, E.M.; Kam, C.W.; et al. Idarucizumab for Dabigatran Reversal—Full Cohort Analysis. N. Engl. J. Med. 2017, 377, 431–441. [Google Scholar] [CrossRef]
- Connolly, S.J.; Crowther, M.; Eikelboom, J.W.; Gibson, C.M.; Curnutte, J.T.; Lawrence, J.H.; Yue, P.; Bronson, M.D.; Lu, G.; Conley, P.B.; et al. Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors. N. Engl. J. Med. 2019, 380, 1326–1335. [Google Scholar] [CrossRef] [PubMed]
- Iaccarino, C.; Carretta, A.; Demetriades, A.K.; Di Minno, G.; Giussani, C.; Marcucci, R.; Marklund, N.; Mastrojanni, G.; Pompucci, A.; Stefini, R.; et al. Management of Antithrombotic Drugs in Patients with Isolated Traumatic Brain Injury: An Intersociety Consensus Document. Neurocrit. Care 2024, 40, 314–327. [Google Scholar] [CrossRef] [PubMed]
- Glund, S.; Moschetti, V.; Norris, S.; Stangier, J.; Schmohl, M.; van Ryn, J.; Lang, B.; Ramael, S.; Reilly, P. A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran. Thromb. Haemost. 2015, 113, 943–951. [Google Scholar]
- Husted, S.; Verheugt, F.W.A.; Comuth, W.J. Reversal Strategies for NOACs: State of Development, Possible Clinical Applications and Future Perspectives. Drug Saf. 2016, 39, 5–13. [Google Scholar] [CrossRef] [PubMed]
- Gendron, N.; Billoir, P.; Siguret, V.; Le Cam-Duchez, V.; Proulle, V.; Macchi, L.; Boissier, E.; Mouton, C.; De Maistre, E.; Gouin-Thibault, I.; et al. Is there a role for the laboratory monitoring in the management of specific antidotes of direct oral anticoagulants? Thromb. Res. 2024, 237, 171–180. [Google Scholar] [CrossRef] [PubMed]
- Health Data and Registers—Sundhedsdatastyrelsen [Internet]. Available online: https://sundhedsdatastyrelsen.dk/da/english/health_data_and_registers (accessed on 25 February 2024).
- Chaudhary, R.; Singh, A.; Chaudhary, R.; Bashline, M.; Houghton, D.E.; Rabinstein, A.; Adamski, J.; Arndt, R.; Ou, N.N.; Rudis, M.I.; et al. Evaluation of Direct Oral Anticoagulant Reversal Agents in Intracranial Hemorrhage: A Systematic Review and Meta-analysis. JAMA Netw. Open 2022, 5, e2240145. [Google Scholar] [CrossRef] [PubMed]
- Edwards, G.; Roman, C.; Jithoo, R.; Mitra, B. Use of Idarucizumab for dabigatran reversal: Emergency department experience in two cases with subdural haematoma. Trauma Case Rep. 2017, 13, 46–49. [Google Scholar] [CrossRef] [PubMed]
- Maruyama, S.; Hayakawa, K.; Kanayama, S.; Iwamura, H.; Wada, D.; Saito, F.; Nakamori, Y.; Kuwagata, Y. Idarucizumab for a traumatic head injury patient taking dabigatran. Int. J. Emerg. Med. 2018, 11, 41. [Google Scholar] [CrossRef]
- Suehiro, E.; Ishihara, H.; Kogeichi, Y.; Ozawa, T.; Haraguchi, K.; Honda, M.; Honda, Y.; Inaba, M.; Kabeya, R.; Kanda, N.; et al. Retrospective observational study of patients with subdural hematoma treated with idarucizumab. Neurotrauma Rep. 2023, 4, 790–796. [Google Scholar] [CrossRef]
- Connolly, S.J.; Milling, T.J., Jr.; Eikelboom, J.W.; Gibson, C.M.; Curnutte, J.T.; Gold, A.; Bronson, M.D.; Lu, G.; Conley, P.B.; Verhamme, P.; et al. Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors. N. Engl. J. Med. 2016, 375, 1131–1141. [Google Scholar] [CrossRef]
- Maragkos, G.A.; Nelton, E.B.; Richter, S.; Stippler, M. Low Risk of Traumatic Intracranial Hematoma Expansion with Factor Xa Inhibitors without Andexanet Reversal. World Neurosurg. 2020, 142, e95–e100. [Google Scholar] [CrossRef] [PubMed]
- Sadek, E.; Curtiss, W.; Andrews, J.; Hecht, J. Four-factor prothrombin complex concentrate versus andexanet alfa for the reversal of traumatic brain injuries. Emerg. Med. J. 2024, 41, 162–167. [Google Scholar] [CrossRef] [PubMed]
- Roberts, I.; Shakur, H.; Coats, T.; Hunt, B.; Balogun, E.; Barnetson, L.; Cook, L.; Kawahara, T.; Perel, P.; Prieto-Merino, D.; et al. The CRASH-2 trial: A randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol. Assess. 2013, 17, 1–79. [Google Scholar] [CrossRef] [PubMed]
- Roberts, I.; Shakur-Still, H.; Aeron-Thomas, A.; Belli, A.; Brenner, A.; Chaudary, M.A.; Chaudhri, R.; Jamaluddin, S.F.; Frimley, L.; Javaid, K. CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): A randomised, placebo-controlled trial. Lancet 2019, 394, 1713–1723. [Google Scholar]
- Sprigg, N.; Flaherty, K.; Appleton, J.P.; Al-Shahi Salman, R.; Bereczki, D.; Beridze, M.; Christensen, H.; Ciccone, A.; Collins, R.; Czlonkowska, A.; et al. Tranexamic Acid for Hyperacute Primary Intracerebral Haemorrhage (TICH-2): An international randomised, placebocontrolled, phase 3 superiority trial. Lancet 2018, 391, 2107–2115. [Google Scholar] [CrossRef] [PubMed]
- Meretoja, A.; Yassi, N.; Wu, T.Y.; Churilov, L.; Sibolt, G.; Jeng, J.S.; Kleinig, T.; Spratt, N.J.; Thijs, V.; Wijeratne, T.; et al. Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): A multicentre, randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2020, 19, 980–987. [Google Scholar] [CrossRef] [PubMed]
- Liu, J.; Nie, X.; Gu, H.; Zhou, Q.; Sun, H.; Tan, Y.; Liu, D.; Zheng, L.; Zhao, J.; Wang, Y.; et al. Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): A multicentre, randomised, placebo-controlled trial. Stroke Vasc. Neurol. 2021, 6, 160–169. [Google Scholar] [CrossRef] [PubMed]
- Polymeris, A.A.; Karwacki, G.M.; Siepen, B.M.; Schaedelin, S.; Tsakiris, D.A.; Stippich, C.; Guzman, R.; Nickel, C.H.; Sprigg, N.; Kägi, G.; et al. Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial. Stroke 2023, 54, 2223–2234. [Google Scholar] [CrossRef]
- Rossaint, R.; Afshari, A.; Bouillon, B.; Cerny, V.; Cimpoesu, D.; Curry, N.; Duranteau, J.; Filipescu, D.; Grottke, O.; Grønlykke, L.; et al. The European guideline on management of major bleeding and coagulopathy following trauma: Sixth edition. Crit. Care 2023, 27, 80. [Google Scholar] [CrossRef]
- Fitschen-Oestern, S.; Franke, G.M.; Kirsten, N.; Lefering, R.; Lippross, S.; Schröder, O.; Klüter, T.; Müller, M.; Seekamp, A.; TraumaRegister, D.G.U. Does tranexamic acid have a positive effect on the outcome of older multiple trauma patients on antithrombotic drugs? An analysis using the TraumaRegister DGU®. Front. Med. 2024, 11, 1324073. [Google Scholar]
- Hawryluk, G.W.J.; Rubiano, A.M.; Totten, A.M.; O’Reilly, C.; Ullman, J.S.; Bratton, S.L.; Chesnut, R.; Harris, O.A.; Kissoon, N.; Shutter, L. Guidelines for the Management of Severe Traumatic Brain Injury: 2020 Update of the Decompressive Craniectomy Recommendations. Neurosurgery 2020, 87, 427–434. [Google Scholar] [CrossRef] [PubMed]
- Bullock, M.R.; Chesnut, R.; Ghajar, J.; Gordon, D.; Hartl, R.; Newell, D.W.; Servadei, F.; Walters, B.C.; Wilberger, J.E.; Surgical Management of Traumatic Brain Injury Author Group. Surgical management of acute subdural hematomas. Neurosurgery 2006, 58 (Suppl. S3), S16–S24. [Google Scholar] [CrossRef] [PubMed]
- Manivannan, S.; Spencer, R.; Marei, O.; Mayo, I.; Elalfy, O.; Martin, J.; Zaben, M. Acute subdural haematoma in the elderly: To operate or not to operate? A systematic review and meta-analysis of outcomes following surgery. BMJ Open 2021, 11, e050786. [Google Scholar] [PubMed]
- Rickard, F.; Gale, J.; Williams, A.; Shipway, D. New horizons in subdural haematoma. Age Ageing 2023, 52, afad240. [Google Scholar] [CrossRef] [PubMed]
- Raymond, K.; Sterling, A.; Roberts, M.; Holland Iii, R.W.; Galwankar, S.; Mishra, R.K.; Agrawal, A. Analysis of traumatic intracranial hemorrhage and delayed traumatic intracranial hemorrhage in patients with isolated head injury on anticoagulation and antiplatelet therapy. J. Neurosci. Rural Pract. 2023, 14, 686–691. [Google Scholar] [CrossRef] [PubMed]
- Vattipally, V.N.; Ran, K.R.; Giwa, G.A.; Myneni, S.; Dardick, J.M.; Rincon-Torroella, J.; Ye, X.; Byrne, J.P.; Suarez, J.I.; Lin, S.C.; et al. Impact of Antithrombotic Medications and Reversal Strategies on the Surgical Management and Outcomes of Traumatic Acute Subdural Hematoma. World Neurosurg. 2024, 182, e431–e441. [Google Scholar] [CrossRef] [PubMed]
- Jung, I.H.; Yun, J.H.; Kim, S.J.; Chung, J.; Lee, S.K. Anticoagulation and Antiplatelet Agent Resumption Timing following Traumatic Brain Injury. Korean J. Neurotrauma 2023, 19, 298–306. [Google Scholar] [CrossRef]
- Margolick, J.; Dandurand, C.; Duncan, K.; Chen, W.; Evans, D.C.; Sekhon, M.S.; Garraway, N.; Griesdale, D.E.G.; Gooderham, P.; Hameed, S.M. A Systematic Review of the Risks and Benefits of Venous Thromboembolism Prophylaxis in Traumatic Brain Injury. Can. J. Neurol. Sci. 2018, 45, 432–444. [Google Scholar] [CrossRef]
- Amer, M.; Alshahrani, M.S.; Arabi, Y.M.; Al-Jedai, A.; Alshaqaq, H.M.; Al-Sharydah, A.; Al-Suwaidan, F.A.; Aljehani, H.; Nouh, T.; Mashbari, H.; et al. Saudi Critical Care Society clinical practice guidelines on the prevention of venous thromboembolism in adults with trauma: Reviewed for evidence-based integrity and endorsed by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine. Ann. Intensive Care 2023, 13, 41. [Google Scholar] [CrossRef]
- Nielsen, P.B.; Larsen, T.B.; Skjøth, F.; Lip, G.Y. Outcomes associated with resuming warfarin Treatment after hemorrhagic stroke or traumatic intracranial hemorrhage in patients with atrial fibrillation. JAMA Intern. Med. 2017, 177, 563–570. [Google Scholar] [CrossRef]
- Albrecht, J.S.; Liu, X.; Baumgarten, M.; Langenberg, P.; Rattinger, G.B.; Smith, G.S.; Gambert, S.R.; Gottlieb, S.S.; Zuckerman, I.H. Benefits and risks of anticoagulation resumption following traumatic brain injury. JAMA Intern. Med. 2014, 174, 1244–1251. [Google Scholar] [CrossRef] [PubMed]
- Puckett, Y.; Zhang, K.; Blasingame, J.; Lorenzana, J.; Parameswaran, S.; Brooks, S.E.; Baronia, B.C.; Griswold, J. Safest Time to Resume Oral Anticoagulation in Patients with Traumatic Brain Injury. Cureus 2018, 10, e2920. [Google Scholar] [CrossRef]
- Naylor, R.M.; Dodin, R.E.; Henry, K.A.; De La Peña, N.M.; Jarvis, T.L.; Labott, J.R.; Van Gompel, J.J. Timing of Restarting Anticoagulation and Antiplatelet Therapies After Traumatic Subdural Hematoma-A Single Institution Experience. World Neurosurg. 2021, 150, e203–e208. [Google Scholar] [CrossRef] [PubMed]
- Matsushima, K.; Leichtle, S.W.; Wild, J.; Young, K.; Chang, G.; Demetriades, D.; EAST ACT-TBI Multicenter Study Group. Anticoagulation therapy in patients with traumatic brain injury: An Eastern Association for the Surgery of Trauma multicenter prospective study. Surgery 2021, 169, 470–476. [Google Scholar] [CrossRef]
- Chipman, A.M.; Radowsky, J.; Vesselinov, R.; Chow, D.; Schwartzbauer, G.; Tesoriero, R.; Stein, D. Therapeutic anticoagulation in patients with traumatic brain injuries and pulmonary emboli. J. Trauma Acute Care Surg. 2020, 89, 529–535. [Google Scholar] [CrossRef]
- Byrnes, M.C.; Irwin, E.; Roach, R.; James, M.; Horst, P.K.; Reicks, P. Therapeutic anticoagulation can be safely accomplished in selected patients with traumatic intracranial hemorrhage. World J. Emerg. Surg. 2012, 7, 25. [Google Scholar] [CrossRef]
- Alshaqaq, H.M.; Al-Sharydah, A.M.; Alshahrani, M.S.; Alqahtani, S.M.; Amer, M. Prophylactic Inferior Vena Cava Filters for Venous Thromboembolism in Adults With Trauma: An Updated Systematic Review and Meta-Analysis. J. Intensive Care Med. 2023, 38, 491–510. [Google Scholar] [CrossRef] [PubMed]
- Fakhry, S.M.; Morse, J.L.; Garland, J.M.; Wilson, N.Y.; Shen, Y.; Wyse, R.J.; Watts, D.D. Antiplatelet and anticoagulant agents have minimal impact on traumatic brain injury incidence, surgery, and mortality in geriatric ground level falls: A multi-institutional analysis of 33,710 patients. J. Trauma Acute Care Surg. 2021, 90, 215–223. [Google Scholar] [CrossRef]
- Chauny, J.M.; Marquis, M.; Bernard, F.; Williamson, D.; Albert, M.; Laroche, M.; Daoust, R. Risk of Delayed Intracranial Hemorrhage in Anticoagulated Patients with Mild Traumatic Brain Injury: Systematic Review and Meta-Analysis. J. Emerg. Med. 2016, 51, 519–528. [Google Scholar] [CrossRef]
- Puzio, T.J.; Murphy, P.B.; Kregel, H.R.; Ellis, R.C.; Holder, T.; Wandling, M.W.; Wade, C.E.; Kao, L.S.; McNutt, M.K.; Harvin, J.A.; et al. Delayed in- tracranial hemorrhage after blunt head trauma while on direct oral anticoagulant: Systematic review and meta-analysis. J. Am. Coll. Surg. 2021, 232, 1007–1016. [Google Scholar] [CrossRef]
- Hadwe, S.E.; Assamadi, M.; Barrit, S.; Giannis, D.; Haidich, A.B.; Goulis, D.G.; Chatzisotiriou, A. Delayed intracranial hemorrhage of patients with mild traumatic brain injury under antithrombotics on routine repeat CT scan: A systematic review and meta-analysis. Brain Inj. 2022, 36, 703–713. [Google Scholar] [CrossRef] [PubMed]
- Cohan, C.M.; Beattie, G.; Bowman, J.A.; Galante, J.M.; Kwok, A.M.; Dirks, R.C.; Kornblith, L.Z.; Plevin, R.; Browder, T.D.; Victorino, G.P. Repeat computed tomography head scan is not indicated in trauma patients taking novel anticoagulation: A multicenter study. J. Trauma Acute Care Surg. 2020, 89, 301–310. [Google Scholar] [CrossRef] [PubMed]
- Turcato, G.; Cipriano, A.; Zaboli, A.; Park, N.; Riccardi, A.; Santini, M.; Lerza, R.; Ricci, G.; Bonora, A.; Ghiadoni, L. Risk of delayed intracranial haemorrhage after an initial negative CT in patients on DOACs with mild traumatic brain injury. Am. J. Emerg. Med. 2022, 53, 185–189. [Google Scholar] [CrossRef] [PubMed]
- Verschoof, M.A.; Zuurbier, C.C.M.; de Beer, F.; Coutinho, J.M.; Eggink, E.A.; van Geel, B.M. Evaluation of the yield of 24-h close observation in patients with mild traumatic brain injury on anticoagulation therapy: A retrospective multicenter study and meta- analysis. J. Neurol. 2018, 265, 315–321. [Google Scholar] [CrossRef]
- Antoni, A.; Schwendenwein, E.; Binder, H.; Schauperl, M.; Datler, P.; Hajdu, S. Delayed in- tracranial hemorrhage in patients with head trauma and antithrombotic therapy. J. Clin. Med. 2019, 8, 1780. [Google Scholar] [CrossRef] [PubMed]
- Cipriano, A.; Pecori, A.; Bionda, A.E.; Bardini, M.; Frassi, F.; Leoli, F.; Lami, V.; Ghiadoni, L.; Santini, M. Intracranial hemorrhage in anticoagulated patients with mild traumatic brain injury: Significant differences between direct oral anticoagulants and vitamin K antagonists. Intern. Emerg. Med. 2018, 13, 1077–1087. [Google Scholar] [CrossRef] [PubMed]
- Hickey, S.; Hickman, Z.L.; Conway, J.; Giwa, A. The Effect of Direct Oral Anti-Coagulants on Delayed Traumatic Intracranial Hemorrhage After Mild Traumatic Brain Injury: A Systematic Review. J. Emerg. Med. 2021, 60, 321–330. [Google Scholar] [CrossRef] [PubMed]
- Flaherty, S.; Biswas, S.; Watts, D.D.; Wilson, N.Y.; Shen, Y.; Garland, J.M.; Wyse, R.J.; Lieser, M.J.; Duane, T.M.; Offner, P.J.; et al. Findings on Repeat Post Traumatic Brain Computed Tomography Scans in Older Patients with Minimal Head Trauma and the Impact of Existing Antithrombotic Use. Ann. Emerg. Med. 2023, 81, 364–374. [Google Scholar] [CrossRef] [PubMed]
- Kockelmann, F.; Maegele, M. Acute Haemostatic Depletion and Failure in Patients with Traumatic Brain Injury (TBI): Pathophysiological and Clinical Considerations. J. Clin. Med. 2023, 12, 2809. [Google Scholar] [CrossRef]
- de Oliveira Manoel, A.L.; Neto, A.C.; Veigas, P.V.; Rizoli, S. Traumatic brain injury associated coagulopathy. Neurocrit. Care 2015, 22, 34. [Google Scholar] [CrossRef]
- Laroche, M.; Kutcher, M.E.; Huang, M.C.; Mitchell, M.J.; Manley, G.T. Coagulopathy After Traumatic Brain Injury. Neurosurgery 2012, 70, 1334–1345. [Google Scholar] [CrossRef] [PubMed]
- Nakae, R.; Murai, Y.; Morita, A.; Yokobori, S. Coagulopathy and Traumatic Brain Injury: Overview of New Diagnostic and Therapeutic Strategies. Neurol. Med.-Chir. 2022, 62, 261–269. [Google Scholar] [CrossRef] [PubMed]
- Maegele, M.; Schöchl, H.; Menovsky, T.; Maréchal, H.; Marklund, N.; Buki, A.; Stanworth, S. Coagulopathy and Haemorrhagic Progression in Traumatic Brain Injury: Advances in Mechanisms, Diagnosis, and Management. Lancet Neurol. 2017, 16, 630–647. [Google Scholar] [CrossRef] [PubMed]
- Cannon, J.W.; Dias, J.D.; Kumar, M.A.; Walsh, M.; Thomas, S.G.; Cotton, B.A.; Schuster, J.M.; Evans, S.L.; Schreiber, M.A.; Adam, E.H.; et al. Use of Thromboelastography in the Evaluation and Management of Patients with Traumatic Brain Injury: A Systematic Review and Meta-Analysis. Crit. Care Explor. 2021, 3, e0526. [Google Scholar] [CrossRef]
- Böhm, J.K.; Güting, H.; Thorn, S.; Schäfer, N.; Rambach, V.; Schöchl, H.; Grottke, O.; Rossaint, R.; Stanworth, S.; Curry, N.; et al. Global Characterisation of Coagulopathy in Isolated Traumatic Brain Injury (ITBI): A CENTER-TBI Analysis. Neurocrit. Care 2021, 35, 184–196. [Google Scholar] [CrossRef]
- Baksaas-Aasen, K.; Gall, L.S.; Stensballe, J.; Juffermans, N.P.; Curry, N.; Maegele, M.; Brooks, A.; Rourke, C.; Gillespie, S.; Murphy, J.; et al. Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): A randomized, controlled trial. Intensive Care Med. 2021, 47, 49–59. [Google Scholar] [CrossRef] [PubMed]
- van Dijck, J.T.J.M.; Dijkman, M.D.; Ophuis, R.H.; de Ruiter, G.C.W.; Peul, W.C.; Polinder, S. In-hospital costs after severe traumatic brain injury: A systematic review and quality assessment. PLoS ONE 2019, 14, e0216743. [Google Scholar]
- Ganau, L.; Syrmos, N.; Ligarotti, G.K.I.; Ganau, M. Seeking a fine balance between effective antithrombotic prophylaxis and safety drug profile in the elderly population: The special case of traumatic brain injury. Acta Neurochir. 2023, 165, 2215–2218. [Google Scholar] [CrossRef]
- Te Ao, B.; Brown, P.; Tobias, M.; Ameratunga, S.; Barker-Collo, S.; Theadom, A.; McPherson, K.; Starkey, N.; Dowell, A.; Jones, K.; et al. Cost of traumatic brain injury in New Zealand: Evidence from a population-based study. Neurology 2014, 83, 1645–1652. [Google Scholar] [CrossRef] [PubMed]
- van Dijck, J.T.J.M.; Mostert, C.Q.B.; Greeven, A.P.A.; Kompanje, E.J.O.; Peul, W.C.; de Ruiter, G.C.W.; Polinder, S. Functional outcome, in-hospital healthcare consumption and in-hospital costs for hospitalised traumatic brain injury patients: A Dutch prospective multicentre study. Acta Neurochir. 2020, 162, 1607–1618. [Google Scholar] [CrossRef]
- Choksi, E.J.; Mukherjee, K.; Kamal, K.M.; Yocom, S.; Salazar, R. Length of Stay, Cost, and Outcomes related to Traumatic Subdural Hematoma in inpatient setting in the United States. Brain Inj. 2022, 36, 1237–1246. [Google Scholar] [CrossRef] [PubMed]
- Kuczawski, M.; Stevenson, M.; Goodacre, S.; Teare, M.D.; Ramlakhan, S.; Morris, F.; Mason, S. Should all anticoagulated patients with head injury receive a CT scan? Decision-analysis modelling of an observational cohort. BMJ Open 2016, 6, e013742. [Google Scholar]
- Barra, M.E.; Das, A.S.; Hayes, B.D.; Rosenthal, E.S.; Rosovsky, R.P.; Fuh, L.; Patel, A.B.; Goldstein, J.N.; Roberts, R.J. Evaluation of andexanet alfa and four-factor prothrombin complex concentrate (4F-PCC) for reversal of rivaroxaban- and apixaban-associated intracranial hemorrhages. J. Thromb. Haemost. 2020, 18, 1637–1647. [Google Scholar] [CrossRef] [PubMed]
- Fanikos, J.; Goldstein, J.N.; Lovelace, B.; Beaubrun, A.C.; Blissett, R.S.; Aragão, F. Cost-effectiveness of andexanet alfa versus four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-related intracranial hemorrhage in the US. J. Med. Econ. 2022, 25, 309–320. [Google Scholar] [CrossRef]
- Topol, E.J. High-performance medicine: The convergence of human and artificial intelligence. Nat. Med. 2019, 25, 44–56. [Google Scholar] [CrossRef] [PubMed]
- Baur, D.; Gehlen, T.; Scherer, J.; Back, D.A.; Tsitsilonis, S.; Kabir, K.; Osterhoff, G. Decision support by machine learning systems for acute management of severely injured patients: A systematic review. Front. Surg. 2022, 9, 924810. [Google Scholar] [CrossRef]
- Alouani, A.T.; Elfouly, T. Traumatic Brain Injury (TBI) Detection: Past, Present, and Future. Biomedicines 2022, 10, 2472. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Rajaei, F.; Cheng, S.; Williamson, C.A.; Wittrup, E.; Najarian, K. AI-Based Decision Support System for Traumatic Brain Injury: A Survey. Diagnostics 2023, 13, 1640. [Google Scholar] [CrossRef]
- Dasic, D.; Morgan, L.; Panezai, A.; Syrmos, N.; Ligarotti, G.K.I.; Zaed, I.; Chibbaro, S.; Khan, T.; Prisco, L.; Ganau, M. A scoping review on the challenges, improvement programs, and relevant output metrics for neurotrauma services in major trauma centers. Surg. Neurol. Int. 2022, 13, 171. [Google Scholar] [CrossRef]
- Tu, K.C.; Eric Nyam, T.T.; Wang, C.C.; Chen, N.C.; Chen, K.T.; Chen, C.J.; Liu, C.F.; Kuo, J.R. A Computer-Assisted System for Early Mortality Risk Prediction in Patients with Traumatic Brain Injury Using Artificial Intelligence Algorithms in Emergency Room Triage. Brain Sci. 2022, 12, 612. [Google Scholar] [CrossRef]
Biomarker | Study | Patients on OAT Included | Analysis of the Patients on OAT | Results | Reference |
---|---|---|---|---|---|
S100B | Biberthaler et al. 2006 | 0/1309 | No | / | [47] |
Laribi et al. 2014 | 0/431 | No | / | [48] | |
Morochovič et al. 2009 | 0/102 | No | / | [49] | |
David et al. 2017 | 83/308 | No | NPV 94.3% (95% CI: 87.2–98.1%) PPV 12.7% (95% CI: 8.6–17.9%) | [54] | |
Menditto et al. | 313/313 | Yes | NPV 86.9% (95% CI: 82.5–90.3%) PPV 15.9% (95% CI: 12.1–20.5%) | [55] | |
NSE | Menditto et al. | 313/313 | Yes | NPV 84.3% (95% CI: 79.7–88.1%) PPV 13.0% (95% CI: 9.6–17.4%) | [55] |
UCHL1 | Menditto et al. | 313/313 | Yes | NPV 88.1% (95% CI: 82.8–91.9%) PPV 17.3% (95% CI: 12.6–23.1%) | [55] |
GFAP | Menditto et al. | 313/313 | Yes | NPV 95.8% (95% CI: 92.0–97.9%) PPV 16.6% (95% CI: 12.0–22.4%) | [55] |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Menditto, V.G.; Rossetti, G.; Sampaolesi, M.; Buzzo, M.; Pomponio, G. Traumatic Brain Injury in Patients under Anticoagulant Therapy: Review of Management in Emergency Department. J. Clin. Med. 2024, 13, 3669. https://doi.org/10.3390/jcm13133669
Menditto VG, Rossetti G, Sampaolesi M, Buzzo M, Pomponio G. Traumatic Brain Injury in Patients under Anticoagulant Therapy: Review of Management in Emergency Department. Journal of Clinical Medicine. 2024; 13(13):3669. https://doi.org/10.3390/jcm13133669
Chicago/Turabian StyleMenditto, Vincenzo G., Giulia Rossetti, Mattia Sampaolesi, Marta Buzzo, and Giovanni Pomponio. 2024. "Traumatic Brain Injury in Patients under Anticoagulant Therapy: Review of Management in Emergency Department" Journal of Clinical Medicine 13, no. 13: 3669. https://doi.org/10.3390/jcm13133669